Cytokinetics
CYTK
CYTK
276 hedge funds and large institutions have $4.88B invested in Cytokinetics in 2022 Q4 according to their latest regulatory filings, with 38 funds opening new positions, 109 increasing their positions, 83 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
0% more funds holding
Funds holding: 276 → 276 (0)
1% less capital invested
Capital invested by funds: $4.95B → $4.88B (-$70.7M)
9% less funds holding in top 10
Funds holding in top 10: 11 → 10 (-1)
Holders
276
Holding in Top 10
10
Calls
$48.3M
Puts
$10.6M
Top Buyers
| 1 | +$78.2M | |
| 2 | +$36.2M | |
| 3 | +$32.9M | |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
+$27.4M |
| 5 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$25.5M |
Top Sellers
| 1 | -$56.8M | |
| 2 | -$43.3M | |
| 3 | -$39.4M | |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$38.2M |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
-$23.5M |